These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10468289)

  • 1. Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).
    Todorov PT; Field WN; Tisdale MJ
    Br J Cancer; 1999 Aug; 80(11):1734-7. PubMed ID: 10468289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation.
    Todorov PT; Deacon M; Tisdale MJ
    J Biol Chem; 1997 May; 272(19):12279-88. PubMed ID: 9139670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.
    Hussey HJ; Todorov PT; Field WN; Inagaki N; Tanaka Y; Ishitsuka H; Tisdale MJ
    Br J Cancer; 2000 Jul; 83(1):56-62. PubMed ID: 10883668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.
    Mirza KA; Tisdale MJ
    Br J Cancer; 2014 Aug; 111(5):903-8. PubMed ID: 25101564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of muscle protein degradation by a tumour factor.
    Lorite MJ; Cariuk P; Tisdale MJ
    Br J Cancer; 1997; 76(8):1035-40. PubMed ID: 9376263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of muscle protein degradation induced by a cancer cachectic factor.
    Lorite MJ; Thompson MG; Drake JL; Carling G; Tisdale MJ
    Br J Cancer; 1998 Oct; 78(7):850-6. PubMed ID: 9764574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).
    Mirza KA; Wyke SM; Tisdale MJ
    Br J Cancer; 2011 Jun; 105(1):83-8. PubMed ID: 21673682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy.
    Deans DA; Wigmore SJ; Gilmour H; Tisdale MJ; Fearon KC; Ross JA
    Br J Cancer; 2006 Mar; 94(5):731-6. PubMed ID: 16495932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.
    Kawamura I; Lacey E; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Goto T
    Anticancer Res; 1999; 19(5B):4091-7. PubMed ID: 10628359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid.
    Hussey HJ; Tisdale MJ
    Br J Cancer; 1999 Jun; 80(8):1231-5. PubMed ID: 10376976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor.
    Mori M; Yamaguchi K; Honda S; Nagasaki K; Ueda M; Abe O; Abe K
    Cancer Res; 1991 Dec; 51(24):6656-9. PubMed ID: 1742740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle.
    Todorov PT; Wyke SM; Tisdale MJ
    Cancer Res; 2007 Dec; 67(23):11419-27. PubMed ID: 18056470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
    Mahony SM; Beck SA; Tisdale MJ
    Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss.
    Cabal-Manzano R; Bhargava P; Torres-Duarte A; Marshall J; Bhargava P; Wainer IW
    Br J Cancer; 2001 Jun; 84(12):1599-601. PubMed ID: 11401311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.
    Beck SA; Tisdale MJ
    Br J Cancer; 1990 Sep; 62(3):420-4. PubMed ID: 2206950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF).
    Lorite MJ; Smith HJ; Arnold JA; Morris A; Thompson MG; Tisdale MJ
    Br J Cancer; 2001 Jul; 85(2):297-302. PubMed ID: 11461093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteolysis induce factor in the digestive systematic cancer cachexia patients: its expression and role in cancer cachexia].
    Han YS; Zhuang QL; Wu GH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Dec; 15(12):1287-90. PubMed ID: 23268279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor.
    Wigmore SJ; Todorov PT; Barber MD; Ross JA; Tisdale MJ; Fearon KC
    Br J Surg; 2000 Jan; 87(1):53-8. PubMed ID: 10606911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of animal models for head and neck cancer cachexia.
    Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
    Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.